Abstract: The purpose of this review is to evaluate the safety of regional anesthesia techniques performed for postoperative analgesia in anesthetized children. Pediatric regional anesthesia techniques, such as nerve blocks and neuraxial injections of either local anesthetics or narcotics, can potentially reduce postoperative pain for all children undergoing surgery. However, children may react differently to anesthesia than adults, and they usually cannot tolerate the administration of regional anesthesia unless they are under general anesthesia.
P ediatric regional anesthesia techniques, comprised primarily of neuraxial (spinal, epidural, or caudal) injections and less commonly peripheral nerve blocks (PNBs), have become increasingly popular. This may be largely due to improvements in administration equipment and local anesthetics. 1Y3 Regional anesthesia techniques, such as nerve blocks and neuraxial injections of local anesthetics or narcotics, can potentially reduce postoperative pain for all children undergoing surgery. However, children may react differently to anesthesia than adults, and drug dosages must be adjusted for their lower weight. In addition, children usually cannot tolerate the administration of regional anesthesia injections unless they are under general anesthesia or deeply sedated; thus the signs of effective or ineffective needle placement, intravascular needle placement, or inadvertent subarachnoid placement are much more indirect. It is for these reasons that concern still exists regarding the safety of regional anesthesia in heavily sedated or anesthetized patients. 5Y10 The purpose of this review is to illustrate the safety of regional anesthesia techniques (both PNBs and neuraxial injections) in anesthetized children.
Little information is available on the efficacy and complications of these blocks when used in children. Only 1 study of a large number of pediatric regional anesthetics has been published. Giaufre et al 4 reported in 1996 on the experience of the French Language Society of Pediatric Anesthesiologists with regional anesthesia in children. Based on a survey of 309 anesthesiologists from 38 institutions in 3 countries, they concluded that regional anesthesia is safe in pediatric patients. Although the primary purpose of their review was to determine the safety of neuraxial blockade, for which respondents reported some complications, and respondents reported no complications from PNBs. However, this study was a survey of anesthesiologists, not a direct evaluation of children undergoing regional anesthesia, and it is possible that complications were underreported using this methodology.
Regional anesthesia has been routinely administered to children undergoing extremity and spine surgery at our institution since 1999. This article reviews our experiences with beginning a program of PNBs and with neuraxial injections, focusing on the safety of their administration in anesthetized children.
METHODS

Data Collection
A retrospective chart review of anesthetic records and postoperative notes of children undergoing surgery at Shriners Hospital for Children Northern California (SHCNC) from July 1, 1999, through June 30, 2004, was performed under a protocol approved by the University of California, Davis Institutional Review Board, to determine the total number of regional anesthetics administered, the number of regional anesthetic procedures performed under general anesthesia, and any complications which may have occurred. Medical records were also reviewed for American Society of Anesthesia (ASA) status, patient age, anesthesiologist, type of regional anesthetic procedure, and whether complications were noted. In addition to anesthesia records and postoperative notes, individual adverse anesthesia event data collected on all patients receiving anesthesia at our institution were reviewed.
Patients undergoing outpatient surgery at SHCNC were telephoned within 24 hours postoperatively to determine if any anesthetic or surgical problems have occurred. Every patient was seen 1 to 6 weeks postoperatively, depending on their operation, when they were further evaluated for postoperative problems. Several safeguards are in place to insure that outpatients attend their postoperative follow-up appointment, including telephone contact and notification by certified mail.
Regional Anesthetic Administration
During the review period, anesthetics were provided or directly supervised by 5 board certified anesthesiologists, none of whom had prior experience with PNBs in children. Inductions of general anesthesia during the review period were done using inhalation agents and/or intravenous propofol, narcotic (remifentanil or fentanyl), and often glycopyrrolate, which was given to prevent bradycardia and to mitigate secretions. No muscle relaxant was given before performing any PNB.
Peripheral nerve blocks were accomplished using the B. Braun Stimuplex nerve stimulator, insulated needles (21-gauge 4-in, 22-gauge 2-in, or 24-gauge 1-in needles manufactured by either Life-Tech, Inc, Stafford, Tex, or B. Braun Medical Inc, Bethlehem, PA) and standard commercial solutions of ropivacaine or bupivacaine. Nerve stimulation was done using currents generally starting at 1.5 mA at 1 or 2 Hz, depending on operator preference. The exact final current settings before injection were determined by the operator. These settings were usually less than 0.5 mA. No minimal current setting was arbitrarily used, but in general, attempts to stimulate at less than 0.4 mA were avoided because of concern for possible undetected intraneural injection.
The choice of local anesthetic was determined by the attending anesthesiologist. Ropivacaine, like bupivacaine, is a long-lasting local anesthetic and is thought to have similar potency and less muscle relaxation properties. In addition, ropivacaine is less cardiotoxic than bupivacaine 11, 12 when given in clinical doses. At the beginning of the review period, ropivacaine was not available. However, because of its diminished cardiotoxicity and similar anesthetizing properties, once available, it became the primary local anesthetic used at the SHCNC. The volume of local anesthetic was calculated on a milligram-per-kilogram basis with a maximum total dose of 3 mg/kg ropivacaine or 2.5 mg/kg bupivacaine. Some patients had multiple extremity procedures requiring more than 1 block. Table 1 shows the average volumes of local anesthetic used for the various blocks.
Sciatic nerve blocks were performed using either a modification of the Labat approach 13 or a modified popliteal approach to the sciatic nerve, 14 in which injection was made where the biceps femoris and semitendinous muscles come together. The axillary, interscalene, and supraclavicular blocks were done using the technique described by Winnie. 15 Neuraxial injections consisted primarily of standard solutions of ropivacaine, bupivacaine (standard isobaric or spinal hyperbaric) and/or preservative-free morphine, fentanyl, or hydromorphone. We used 24-gauge Sprotte needles for intrathecal injections. For lumbar epidural injections, we used either 20-or 18-gauge Tuohy needles (B. Braun). Caudal injections were done using either 22-gauge needles or 20-gauge intravenous catheters inserted for injection.
All patients were transferred after surgery to either the postanesthesia care unit or the intensive care unit for recovery. All patients who received neuraxial narcotics were monitored for oxygen saturation and respiratory rate during the first 24 hours after neuraxial injection.
RESULTS
During the review period, 1809 patients out of 7321 (24.7%) patients anesthetized at SHCNC had 2236 PNBs and/ or neuraxial injections. All were under general anesthesia when the regional anesthetic procedure was performed. Ninety-one percent of patients (1641) underwent orthopaedic extremity or spine surgery; the remainder underwent acute or reconstructive burn surgery. Many patients had multiple nerve blocks during the same anesthetic, causing the total number of regional procedures to be greater than the number of patients. Ages ranged from 2 months to 20 years. Sixty-five percent (1169) of all patients included in this review were between 6 months and 12 years of age.
The American Society of Anesthesiologists (ASA) status is a classification used to delineate the preoperative physical status of patients undergoing surgery. Most patients undergoing regional anesthesia were classified as ASA I (824 [45.5%]) or ASA II (845 [46.7%]). One hundred twenty-five (6.9%) were classified as ASA III and 8 (G1%) were classified as ASA IV; ASA status was not documented for 7 patients.
A total of 1011 lower extremity blocks were completed. This included 40 lateral femoral cutaneous nerve blocks, 2 anterior approaches to the sciatic nerve, and 11 saphenous nerve blocks. A total of 646 upper extremity nerve blocks and 579 neuraxial procedures were performed. In 88% of patients who received a PNB, ropivacaine was used; the remainder received bupivacaine. Neuraxial procedures were spinal, lumbar epidural, and caudal injections of either local anesthetic and/or preservative-free narcotic.
A total of 1657 PNBs were performed in 1488 patients. A distribution of PNBs performed by patient age is shown in Table 2 . Sixty-nine percent of all PNBs (1139) were done in children between the ages of 6 months and 12 years. A total of 454 PNBs were done in children aged 3 years or younger. Thirty-two PNBs were performed in patients younger than 6 months.
An age distribution of patients receiving neuraxial injections is shown in Table 3 . Two hundred eighteen patients received spinal injections of narcotics for postoperative pain control from spine surgery. No complications were noted in patients receiving neuraxial injections under general anesthesia.
The charts of the 454 children younger than 3 years who received PNB's revealed no documentation of prolonged crying, irritability, or other behavioral changes. Review of all the records revealed 2 complications that were possibly related to PNBs. In one 16-year-old patient, severe hypotension occurred 30 minutes after 2 upper extremity nerve blocks (left axillary block followed by a right interscalene block using 0.5% ropivacaine). Hypotension (50/30 mm Hg lasting less than 5 min) was treated with 100 Kg epinephrine and subsequently 20 mg ephedrine. Coincidentally, 1 g of cefazolin was given at about the same time as completion of the second PNB. The total dosage of the local anesthetic given for the 2 upper extremity blocks was 2.6 mg/kg ropivacaine. In the postanesthesia care unit (2 h after the interscalene block), the patient was awake and there was no evidence of an intrathecal injection. There were no neurological sequelae in this case. The second complication was found on referral from the clinic on the first postoperative visit. This patient was a 16-year-old girl who had paresthesias on the day following a distal femoral osteotomy. She had received a femoral nerve block under general anesthesia. Paresthesias emanated near the site of the femoral injection of local anesthetic and surgical tourniquet application. Her initial tourniquet time was 124 minutes at 275 mm Hg; the tourniquet was then released for 20 minutes for reperfusion and then elevated again to 275 mm Hg for an additional 42 minutes until completion of the surgical procedure. Medication for neurogenic pain was prescribed but not taken because by 1 month postoperatively, the paresthesias resolved spontaneously. It is unclear whether the parethesias were caused by the femoral block or a prolonged tourniquet time.
DISCUSSION
Our findings corroborate the 1994 study by the French Speaking Society of Anesthesiologists regarding the safety of PNBs in pediatric patients. 4 Our review differs in that it is a single hospital review of the work of 5 anesthesiologists without prior experience in pediatric PNBs. In both studies, minor complications, such as transient paresthesia, headache, transient numbness, and others, may have gone unreported, and very young patients may not have these complaints documented. Although patients aged 3 years or younger may not be able to describe persistent paresthesia or major problems secondary to nerve blocks, our review of 454 PNBs in this age group revealed no documentation of prolonged crying, irritability, other behavioral changes, or complaints from parents/ guardians, which might suggest that a major or persistent problem was present.
Interscalene blocks are known to cause hemidiaphragm weakness; in adults, this does not usually cause respiratory problems 16 but the incidence of this complication is not known in children. In the study by Giaufre et al, 4 respondents reported 144 Bsupraclavicular^blocks in patients ranging from 1 month to 12 years of age without noting complications. Ten of these blocks were performed in patients aged 3 years or younger. In our review of 126 interscalene blocks performed in patients younger than 12 years, we also did not find any respiratory complications. In the 23 patients younger than 3 years, we found no documentation of postoperative respiratory difficulty and none required postoperative ventilatory assistance.
Unlike the study of Giaufre et al, 4 we found no complications associated with neuraxial injections. However, our review had fewer patients who received neuraxial injections. Many of our injections involved neuraxial narcotics only. In our limited number of spinal injections, we noted no postdural puncture headaches. This seems to support the findings of previous studies which indicate that There were no patients who had respiratory depression requiring pharmacologic reversal of the neuraxial narcotics. Also, many of our patients who received spinal injections (218 of 309) underwent posterior or anterior-posterior spine fusions. Complaints of backache in these patients cannot be attributed to the anesthetic. Although we noted 2 complications in this review, it is possible that both complications were unrelated to PNBs. Neither of the 2 documented complications was long-lasting or had serious consequences.
Many anesthesiologists are deterred from providing regional anesthesia procedures in pediatric patients because these patients may need to be heavily sedated or anesthetized. One reason for choosing this review period (July 1999YJune 2004) is that it represents the time when the SHCNC first began to provide PNBs in children. Although none of the anesthesiologists had prior experience with PNBs in children, all had at least limited experience with PNBs in adults and neuraxial injections in both adult and pediatric patients. At the start of the review period, only 1 anesthesiologist was performing PNBs. The positive response to the postoperative analgesia by nursing staff, surgeons, patients, and family led other anesthesiologists to begin providing PNBs for their surgical patients. Because not all anesthesiologists were skilled at every nerve block, assistance from a more experienced provider was available if the attending anesthesiologist needed assistance. This review period arguably represents a time when complications from injections were most likely. Also, it evaluates our safety record during the start of this program. As a precaution, we recommend a low threshold for discontinuing the attempt to administer regional anesthesia, if attempts at needle placement are difficult.
Although the possibility of inadvertent intravascular, intraneural, or intraspinal injections exists and complications of regional anesthetic procedures, such as those described by Giaufre et al, 4 Benumof, 6 and Passannante, 8 can potentially occur, our review of 1657 PNBs and 579 neuraxial procedures concurs with Giaufre et al 4 (1393 upper and lower extremity blocks and 15,013 neuraxial procedures) that regional techniques can be safely performed in pediatric patients under general anesthesia.
Our review involved primarily healthy patients, and few PNBs or neuraxial injections were done in patients younger than 6 months. It is difficult to assess the safety in this age group, particularly when there are physiologic reasons such as immature renal and hepatic systems, which may predispose them to increased risk. Our review and that of Giaufre et al should be considered preliminary. A prospective study assessing adverse events and efficacy is needed.
